Learning from patient-derived autoantibodies to understand human tumor biology and identify new targets.
18 Jun 2024
Salon D
Tumor Microenvironment (TME)
- Why cancer patients develop anti-cancer autoantibodies?
- How to isolate those antibodies?
- How to leverage the spontaneous antibody response for target and therapy discovery?
Industry Expert
